US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Virtus U.S. Dividend ETF

27.96

+0.40021.45%

Volume:104.00

Turnover:2.91K

Market Cap:16.78M

PE:- -

High:27.96

Open:27.96

Low:27.96

Close:27.56

52wk High:27.96

52wk Low:24.79

Shares:600.00K

Float Shares:600.00K

Volume Ratio:1.98

T/O Rate:0.02%

Dividend:0.22

Dividend Rate:0.79%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Rhythm Pharmaceuticals to Report First Quarter 2026 Financial Results on Tuesday, May 5, 2026

Rhythm Pharmaceuticals Announces Changes to Board of Directors

Rhythm Pharmaceuticals Receives Positive CHMP Opinion for IMCIVREE® (setmelanotide) for the Treatment of Obesity and Control of Hunger in Patients with Acquired Hypothalamic Obesity due to Hypothalamic Injury or Impairment

Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE® (setmelanotide) for Patients with Acquired Hypothalamic Obesity

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/VUS"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"VUS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VUS\",,,,,undefined,":{"symbol":"VUS","market":"US","secType":"STK","nameCN":"Virtus U.S. Dividend ETF","latestPrice":27.96,"timestamp":1776369600000,"preClose":27.5598,"halted":0,"volume":104,"delay":0,"changeRate":0.014521150371192885,"floatShares":600004,"shares":600004,"eps":0,"marketStatus":"Closed","change":0.4002,"latestTime":"04-16 16:00:00 EDT","open":27.96,"high":27.96,"low":27.96,"amount":2908.225,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1776412800000},"marketStatusCode":5,"adr":0,"exchange":"ARCA","adjPreClose":27.5598,"sharesOutstanding":625004,"nav":27.969,"aum":16781750.16,"dividendRate":0.007886,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":28.53,"preClose":27.5598,"latestTime":"07:53 EDT","volume":1,"amount":28.53,"timestamp":1776340404069,"change":0.9702,"changeRate":0.035203,"amplitude":0},"volumeRatio":1.984732},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VUS\",,,,,undefined,":{"symbol":"VUS","floatShares":600004,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.984732,"shares":600004,"dividePrice":0.2205,"high":27.96,"amplitude":0,"preClose":27.5598,"low":27.96,"week52Low":24.79,"pbRate":"--","week52High":27.96,"institutionHeld":0,"latestPrice":27.96,"eps":0,"divideRate":0.007886,"volume":104,"delay":0,"ttmEps":0,"open":27.96,"prevYearClose":25.2797,"prevWeekClose":26.2395,"prevMonthClose":25.1704,"prevQuarterClose":25.1704,"fiveDayClose":26.2395,"twentyDayClose":26.693,"sixtyDayClose":26.172},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VUS\",params:#limit:5,,,undefined,":[{"date":"2026-03-20","symbol":"VUS","amount":0.2199,"announcedDate":"2026-03-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-20","defaultRemindTime":1774013400000,"name":"Virtus U.S. Dividend ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-20","currency":"USD","dateTimestamp":1773979200000,"payDate":"2026-03-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VUS\",market:\"US\",,,undefined,":[{"executeDate":"2026-03-20","recordDate":"2026-03-20","paymentDate":"2026-03-27","value":0.2199,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VUS\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VUS\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2626718729","title":"Rhythm Pharmaceuticals to Report First Quarter 2026 Financial Results on Tuesday, May 5, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2626718729","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626718729?lang=en_us&edition=fundamental","pubTime":"2026-04-09 20:00","pubTimestamp":1775736000,"startTime":"0","endTime":"0","summary":"BOSTON, April  09, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with r","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/09/3270878/0/en/Rhythm-Pharmaceuticals-to-Report-First-Quarter-2026-Financial-Results-on-Tuesday-May-5-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EC","VUS","AVP","BK4201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624650779","title":"Rhythm Pharmaceuticals Announces Changes to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2624650779","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624650779?lang=en_us&edition=fundamental","pubTime":"2026-04-03 21:00","pubTimestamp":1775221200,"startTime":"0","endTime":"0","summary":"-- Kim Popovits appointed as new Director; Ed Mathers to depart -- BOSTON, April  03, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/03/3268007/0/en/Rhythm-Pharmaceuticals-Announces-Changes-to-Board-of-Directors.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4201","AVP","VUS","EC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622868600","title":"Rhythm Pharmaceuticals Receives Positive CHMP Opinion for IMCIVREE® (setmelanotide) for the Treatment of Obesity and Control of Hunger in Patients with Acquired Hypothalamic Obesity due to Hypothalamic Injury or Impairment","url":"https://stock-news.laohu8.com/highlight/detail?id=2622868600","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622868600?lang=en_us&edition=fundamental","pubTime":"2026-03-26 21:01","pubTimestamp":1774530060,"startTime":"0","endTime":"0","summary":"-- European Commission decision anticipated in second quarter of 2026 -- BOSTON, March  26, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/26/3263104/0/en/Rhythm-Pharmaceuticals-Receives-Positive-CHMP-Opinion-for-IMCIVREE-setmelanotide-for-the-Treatment-of-Obesity-and-Control-of-Hunger-in-Patients-with-Acquired-Hypothalamic-Obesity-d.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EC","CHMP","BK4087","BK4081","AVP","EMA","VUS","BK4201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620627296","title":"Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE® (setmelanotide) for Patients with Acquired Hypothalamic Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2620627296","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620627296?lang=en_us&edition=fundamental","pubTime":"2026-03-20 06:30","pubTimestamp":1773959400,"startTime":"0","endTime":"0","summary":"David Meeker Quote   David Meeker Quote   Dr. Shoemaker quote   Dr. Shoemaker quote   IMCIVREE packaging   IMCIVREE packaging with vial   IMCIVREE 3D Render   IMCIVREE 3D Render  -- First and only FDA","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/19/3259502/0/en/Rhythm-Pharmaceuticals-Announces-FDA-Approval-of-IMCIVREE-setmelanotide-for-Patients-with-Acquired-Hypothalamic-Obesity.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VUS","EC","LABU","BK4201","BK4588","BK4585","BMI","AVP","BK4157"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":10,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/VUS\",params:#limit:6,delay:false,,,undefined,":[]}}